South Carolina General Assembly
126th Session, 2025-2026

Download This Bill in Microsoft Word Format

Indicates Matter Stricken
Indicates New Matter

H. 4641

STATUS INFORMATION

General Bill
Sponsors: Reps. Pope, Gilliam, Wooten, Oremus, Chapman, McCravy, B. Newton, Martin, White, Schuessler, Ford, Jordan, M.M. Smith, Robbins, Gatch, Duncan, Lastinger, Ligon, Hixon and Ballentine
Companion/Similar bill(s): 4636
Document Path: LC-0352VR26.docx

Introduced in the House on January 13, 2026
Introduced in the Senate on April 30, 2026
Last Amended on April 29, 2026
Currently residing in the Senate Committee on Medical Affairs

Summary: Kratom

HISTORY OF LEGISLATIVE ACTIONS

Date Body Action Description with journal page number
12/16/2025 House Prefiled
12/16/2025 House Referred to Committee on Judiciary
1/13/2026 House Introduced and read first time (House Journal-page 44)
1/13/2026 House Referred to Committee on Judiciary (House Journal-page 44)
1/20/2026 House Member(s) request name added as sponsor: White
1/21/2026 House Member(s) request name added as sponsor: Schuessler
2/11/2026 House Member(s) request name added as sponsor: Ford, Jordan, M.M. Smith, Robbins, Gatch
3/4/2026 House Member(s) request name added as sponsor: Duncan
3/25/2026 House Member(s) request name added as sponsor: Lastinger
4/15/2026 House Committee report: Favorable with amendment Judiciary (House Journal-page 4)
4/21/2026 House Member(s) request name added as sponsor: Ligon, Hixon
4/21/2026 House Amended (House Journal-page 26)
4/21/2026 House Requests for debate-Rep(s). McCravy, Duncan, Beach, Cromer, Gilreath, Edgerton, Long, Burns, Ford (House Journal-page 28)
4/23/2026 House Debate adjourned (House Journal-page 172)
4/29/2026 House Member(s) request name added as sponsor: Ballentine
4/29/2026 House Amended (House Journal-page 156)
4/29/2026 House Read second time (House Journal-page 156)
4/29/2026 House Roll call Yeas-87 Nays-7 (House Journal-page 171)
4/30/2026 House Read third time and sent to Senate (House Journal-page 126)
4/30/2026 House Roll call Yeas-98 Nays-4 (House Journal-page 126)
4/30/2026 Senate Introduced and read first time (Senate Journal-page 7)
4/30/2026 Senate Referred to Committee on Medical Affairs (Senate Journal-page 7)

View the latest legislative information at the website

VERSIONS OF THIS BILL

12/17/2025
04/15/2026
04/21/2026
04/29/2026



Indicates Matter Stricken

Indicates New Matter

 

Amended

April 29, 2026

 

H. 4641

 

Introduced by Reps. Pope, Gilliam, Wooten, Oremus, Chapman, McCravy, B. Newton, Martin, White, Schuessler, Ford, Jordan, M. M. Smith, Robbins, Gatch, Duncan, Lastinger, Ligon, Hixon and Ballentine

 

S. Printed 4/29/26--H.

Read the first time January 13, 2026

 

________


 

 

 

 

 

 

 

 

A bill

 

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-190, RELATING TO SCHEDULE I CONTROLLED SUBSTANCES, SO AS TO ADD KRATOM TO THE CONTROLLED SUBSTANCES LISTED IN SCHEDULE I; AND BY REPEALING ARTICLE 20 OF CHAPTER 53, TITLE 44 RELATING TO THE SOUTH CAROLINA KRATOM CONSUMER PROTECTION ACT.

    Amend Title To Conform

 

Be it enacted by the General Assembly of the State of South Carolina:

 

SECTION 1.  Section 44-53-2020(A) of the S.C. Code is amended to read:

 

    (A) It is unlawful for a kratom processor or kratom retailer to:

       (1) distribute, dispense, or sell any kratom product to any individual under twenty-one years of age;  or

       (2) prepare, manufacture, distribute, dispense, or sell any kratom product that:

           (a) is adulterated with a dangerous non-kratom substance that affects the quality or strength of the product to such a degree that it may injure a consumer;

           (b) contains a poisonous or otherwise harmful non-kratom ingredient including, but not limited to, any substance listed in Section 44-53-190, 44-53-210, 44-53-230, 44-53-250, or 44-53-270;

           (c) contains a an fully synthetic alkaloid including, but not limited to, fully synthetic mitragynine, fully synthetic 7-hydroxymitragynine, or any other fully synthetically derived compound of the plant mitragyna speciosa;

           (d) contains levels of residual solvents higher than the standards set forth in Chapter 467 of the U.S. Pharmacopeia-National Formulary (USP-NF);  or

           (e) does not meet the labeling requirements established pursuant to Section 44-53-2030 and a regulation promulgated to implement the provisions of that section.

 

SECTION 2.  Section 44-53-190 of the S.C. Code is amended by adding:

 

    (G) Any alkaloid, salt, isomer, compound, derivative, precursor, homologue, analogue, or other preparation thereof, that is substantially chemically equivalent or identical to kratom and including, but not limited to, mitragynine, 7-hydroxymitragynine, or any other synthetically derived compound of the plant mitragyna speciosa.

 

SECTION 3.  This act takes effect upon approval by the Governor.

----XX----

 

This web page was last updated on April 29, 2026 at 11:32 PM